From: Higher comorbidities and early death in hospitalized African-American patients with Covid-19
Laboratory values (reference range) | Time of determination (n) | Survivors | Non-survivors | 95% CI | P value |
---|---|---|---|---|---|
Median (Inter Quartile Range) | |||||
Hematologic parameters | |||||
Hemoglobin (12–16 g/dL) | At admission (286) | 12.3 (11.0–14.0) | 12.7 (11.3–14.3) | −0.9 - 0.1 | 0.13 |
48–96 h (228) | 12.0 (10.15–13.1) | 11.7 (10.5–13.3) | −0.6 - 0.5 | 0.83 | |
Leukocyte count (3.5–10.8 K/μL) | At admission (285) | 7.2 (5.4–9.3) | 8.6 (6.4–11.3) | −2.3 - -0.7 | < 0.001 |
48–96 h (228) | 6.5 (5.1–9.4) | 10.6 (7.8–14.3) | −4.9 - -2.7 | < 0.001 | |
Neutrophil Count (1.7–7 K/μL) | on admission (270) | 5.8 (3.8–7.8) | 7.3 (4.8–10.0) | − 2.3 - -0.8 | < 0.001 |
48–96 h (205) | 5.4 (3.4–7.6) | 8.9 (6.4–12.5) | −4.8, − 2.5 | < 0.001 | |
Lymphocyte count (0.9–2.9 K/μL) | on admission (260) | 0.9 (0.7–1.1) | 0.8 (0.6–1.1) | −5.4e - -5, 0.2 | 0.04 |
48–96 h(205) | 1.0 (0.8–1.3) | 0.8 (0.5–1.2) | 0.1–0.3 | 0.002 | |
Neutrophil Lymphocyte count (NLR) | on admission (260) | 5.4 (3.7–8.1) | 8.3 (5.3–13.7) | −3.8 - -1.4 | < 0.001 |
48–96 h (204) | 4.7 (3.3–7.0) | 10.0 (6.06–19.5) | −6.7 - -3.2 | < 0.001 | |
Eosinophil count (0.0–0.8 K/μL) | on admission (255) | 0.03 (0.01–0.07) | 0.02 (0.01–0.04) | 0.002–0.01 | < 0.001 |
48–96 h (203) | 0.05 (0.02–0.1) | 0.01 (0.01–0.04) | 0.01–0.03 | < 0.001 | |
Platelet count (130–400 K/μL) | on admission (283) | 204 (158–266) | 200 (147–260) | −11.0 - 28 | 0.40 |
48–96 h (225) | 229 (153–338) | 194 (150–280) | − 5.9 - 53.9 | 0.11 | |
Blood Chemistry | |||||
Sodium (136–145 mmol/L) | on admission (286) | 136 (133–138) | 136 (132–141) | − 2.0 - 1.0 | 0.51 |
48–96 h (237) | 138 (136–140) | 142 (137–147) | − 5.9 - -2.0 | < 0.001 | |
Potassium (3.5–5.1 mmol/L) | on admission (286) | 4.2 (3.8–4.8) | 4.4 (3.9–5.0) | − 0.4 - 4.9e-5 | 0.04 |
48–96 h (235) | 4.3 (4.0–4.6) | 4.4 (3.9–5) | − 0.4 - 5.2e-5 | 0.05 | |
Bicarbonate (23.0–28.0 mmol/L) | on admission (196) | 25 (22–30) | 22 (19–26) | 1.0–4.9 | 0.001 |
48–96 h (143) | 24 (21–28) | 21 (18–24) | 1.6–5.0 | <.0.001 | |
Chloride (98–107 mmol/L) | on admission (285) | 100 (94–103) | 100 (96–105) | − 3.9 - 3.5e-5 | 0.09 |
48–96 h (238) | 102 (96–106) | 107 (101–113) | − 8.0 - -3.0 | < 0.001 | |
Magnesium (1.9–2.7 mg/dL) | on admission (159) | 2 (1.8–2.2) | 2.2 (1.9–2.6) | − 0.30 - -2.9e-5 | 0.014 |
48–96 h (164) | 2.2 (1.8–2.3) | 2.4 (2.1–2.7) | − 0.4 - -0.2 | < 0.001 | |
BUN (7–25 mg/dL) | on admission (285) | 22 (14–38) | 33 (19–54) | − 14.0 - -5.0 | < 0.001 |
48–96 h (235) | 20 (14–40) | 38 (23–67) | − 22.0 - -10 | < 0.001 | |
Serum creatinine (0.7–1.3 mg/dL) | on admission (286) | 1.3 (1.0–2.4) | 1.7 (1.2–2.6) | − 0.5 - -0.1 | 0.008 |
48–96 h (237) | 1.2 (0.8–2.3) | 1.6 (1.1–3.1) | −0.6 - -0.1 | 0.003 | |
Glucose – random (70–99 mg/dL) | on admission (286) | 128 (104–184) | 182 (129–275) | − 61.0 - -23.0 | < 0.001 |
48–96 h (240) | 103 (84–140) | 163 (119–269) | − 72.9 - -35.9 | < 0.001 | |
AST (13–39 μ/L) | on admission (284) | 40 (26–65) | 52 (38–83) | − 19.0 - -5.0 | < 0.001 |
48–96 h (224) | 49 (28–66) | 64 (37.7–106.2) | − 29.0 - -8.0 | < 0.001 | |
ALT (7–52 μ/L) | on admission (284) | 24 (16–38) | 29 (19–44) | − 7.0 - 0.1 | 0.11 |
48–96 h (224) | 28 (17–52) | 34 (22–57) | − 10.0 - 2.0 | 0.22 | |
Alk Phosphatase (34–104 U/L) | on admission (284) | 64 (49–78) | 66 (54–96) | − 15.0 - -1.0 | 0.02 |
48–96 h (223) | 59 (46–78) | 75 (52–111) | − 27.0 - -7.0 | < 0.001 | |
Bilirubin (0.3–1 mg/dL) | on admission (280) | 0.5 (0.4–0.8) | 0.6 (0.5–0.8) | − 0.1 - 5.0e-5 | 0.28 |
48–96 h (219) | 0.5 (0.4–0.8) | 0.7 (0.5–.9) | − 0.2 - -5.4e-5 | 0.002 | |
Total protein (6–8.3 g/dL) | on admission (282) | 7 (6.5–7.3) | 6.7 (6.4–7.2) | −2.6e-5 - 0.3 | 0.12 |
48–96 h (219) | 6.2 (5.9–6.6) | 6 (5.5–6.7) | − 6.0e-5 - 0.4 | 0.10 | |
Albumin (3.5–5.7 g/dL) | on admission (283) | 3.6 (3.2–4.0) | 3.4 (3.1–3.6) | 0.1–0.3 | < 0.001 |
48–96 h (223) | 3.0 (2.7–3.2) | 2.8 (2.5–3.0) | 0.1–0.3 | < 0.001 | |
LDH (14–271 U/L) | on admission (201) | 379 (280–500) | 551 (411–743) | 106.0–22,849 | < 0.001 |
48–96 h (82) | 406 (278–553) | 638 (444.5–867) | 106.9–339.0 | < 0.001 | |
CRP (< 10 mg/L) | on admission (201) | 117 (63–197) | 180 (128–283) | −97.0 - -36.9 | < 0.001 |
48–96 h (85) | 96 (41–185) | 283 (188–338) | −200.0 - -88.9 | < 0.001 | |
Troponin I (<=0.15 ng/mL) | on admission (170) | 0.03 (0.02–0.12) | 0.08 (0.02–0.21) | 3.6e-5 - 0.06 | 0.010 |
48–96 h (61) | 0.11 (0.02–0.26) | 0.15 (0.06–0.40) | − 0.03 - 0.18 | 0.30 | |
Ferritin (14–233 ng/mL) | on admission (190) | 654.5 (303–1151) | 955 (539.0–2114.6) | 118.5–566.5 | 0.002 |
48–96 h (95) | 768.5 (439–1821) | 1614.1 (499.7–2801.5) | − 37.3, − 1036.7 | 0.08 | |
Procalcitonin (0–0.10 ng/mL) | on admission(172) | 0.32 (0.10–0.96) | 1.03 (0.36–3.78) | 0.19–0.88 | < 0.001 |
48–96 h (69) | 0.34 (0.25–2.47) | 1.68 (0.41–7.35) | 4.75e-5 - 2.77 | 0.049 | |
D-dimer < 0.4 mcg/ml | on admission (50) | 3.3 (1.3–5.2) | 1.5 (0.5–5.2) | −1.02 - 2.6 | 0.39 |
48–96 h (43) | 0.5 (0.5–1.5) | 3.0 (1.1–7.5) | − 4.5 - -0.2 | < 0.001 | |
Coagulation Parameters | |||||
aPTT (25.4–38.6 s) | on admission (126) | 29.9 (28.4–32.4) | 29.0 (26.9–33.6) | −1.9 - 1.5 | 0.68 |
48–96 h (44) | 30.7 (28.0–36.2) | 31.1 (27.9–39.0) | − 6.3 - 6.3 | 0.99 | |
PT (10.8–13.7 s) | on admission (113) | 13.0 (12.2–13.7) | 13.5 (12.6–15.4) | 5.1–1.3 | 0.04 |
48–96 h(43) | 13.1 (11.9–15.2) | 17.2 (13.3–20.2) | 4.94e-5 - 6.7 | 0.04 | |
INR (1 U) | on admission (113) | 1.1 (1.0–1.1) | 1.1 (1.0–1.3) | − 7.12e-6 - 0.10 | 0.07 |
48–96 h (41) | 1.0 (1.0–1.2) | 1.4 (1.1–1.6) | 7.49e-6 - 0.50 | 0.02 |